Our Research

At the Jacobs School, we advance research and discovery to improve health for all. Our multidisciplinary research advances basic and clinical science; we translate those discoveries into clinical care that improves health in our communities. With our eyes on the future, we are increasing the number of students and trainees who pursue careers in research, biomedical science and academic medicine.

Genetics Can Predict — and Help Improve — How Patients Fare After Bariatric Surgery
9/28/23

Clinicians treating severe obesity have a new genetic tool for predicting — and ultimately improving — bariatric surgery outcomes. 

previous next
UB Neurosurgery Plays Key Role at CNS Meeting
9/26/23

The department was recognized with having the most accepted abstracts at the Congress of Neurological Surgeons’ meeting, led by chair Elad I. Levy, MD.

previous next
Sullivan Awarded RO1 Grant to Further RNA Research
9/15/23

John “Jack” M. Sullivan, MD, PhD, professor of ophthalmology in the Jacobs School of Medicine and Biomedical Sciences, has been awarded a four-year National Eye Institute RO1 grant to continue research in RNA therapeutics.

previous next
UB Researchers Discover How Gene May Protect Against Neurodegeneration
9/18/23

Researchers have discovered how an active form of a gene present in 75% of the human population works to protect the brain against neurodegeneration. 

previous next
Study: E-Cigarettes Could Be Potential Smoking Cessation Aid During Pregnancy
9/12/23

Researchers have found that people using e-cigarettes before pregnancy were more likely than those using nicotine replacement therapy to abstain from smoking later in pregnancy.

previous next

Learn More About Our Research

Our Experts in the News

Read more

Recent Publications

See more

Recent Research Funding

  • NIH NCATS ASPIRE Design Award. Ram Samudrala (Principal Investigator). NIH. $100,000. 9/1/2019-1/1/2030.
  • NIH NCATS ASPIRE Reduction-to-Practice Award. Ram Samudrala (Co-Principal Investigator). NCATS. $1,220,000. 8/1/2021-1/1/2030.
  • Residency Training in Mental and Behavioral Health (PCTE-RTMB). Andrew Symons (Co-Principal Investigator). Health Resources and Services Administration. $2,500,000. 1/1/2023-12/1/2028.
  • Investigating the Action and Physiological Role of Slc4a11 in the Cornea. Mark Parker (Principal Investigator). NIH National Eye Institute. 1/1/2018-9/1/2028.
  • Therapeutic targeting of master regulators in non-canonical AR driven advanced lethal prostate cancers. Wilma Hofmann (Co-Investigator). NIH/NCI. 8/1/2023-7/1/2028.
See more